B2K9Q3 AF NFT

Dual-specificity RNA methyltransferase RlmN

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiba733bghptvdk6qe5gphvlrbju3kyptzsiyls2ukoactn5nws46m/metadata.json
IPFS of structure file: 
bafybeidkmr7vyihog7f6kk5mb6ezuavzyhy6x6memhy7seahj5dco3hk44/AF-B2K9Q3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xD46DA32B7720c71602C83cB010B3A9c4840f5D93
First NFT owner address (bech32): 
genesis163k6x2mhyrr3vqkg8jcppvafcjzq7hvn64lp0n
Current NFT ID #378674 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
378674
Accession (UniProt):
B2K9Q3
Name::
Dual-specificity RNA methyltransferase RlmN
Experimental Method:
Predicted structure
Sequence source:
Yersinia pseudotuberculosis serotype IB (strain PB1/+)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2K9Q3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2K9Q3|RLMN_YERPB Dual-specificity RNA methyltransferase RlmN OS=Yersinia pseudotuberculosis serotype IB (strain PB1/+) OX=502801 GN=rlmN PE=3 SV=1 MSEQLLTASTPIDAAPLSDNTVQTTAPATSKINLLDLNRQQMREFFAEMGEKPFRADQVMKWMYHYCYDDFEQMTDINKGLRAKLQRVAEIRAPEVAEEQRSVDGTIKWAIKVGDQQVETVYIPEADRATLCVSSQVGCALECKFCSTAQQGFNRNLRVSEIIGQVWRAAKIIGSLKSTGTRPITNVVMMGMGEPLLNLNNVVPAMDIMMDDFGFGLSKRRVTLSTSGVVPALDKLGDMIDVALAISLHAPTDDIRDEIVPINRKYNIEMFLAAVRRYLDKSKANGGRVTVEYVMLDHINDSTEQAHQLAECLKDTPCKINLIPWNPFPGAPYGRSSNSRVDRFSKVLMEYGFTTIVRKTRGDDIDAACGQLAGEVIDRTKRTLKKKMAGEPIAIKTV